By providing a 3-month supply of medication and all necessary supplies up front, patients stay fully equipped, avoid treatment gaps, and remain psychologically engaged in their journey leading to better outcomes and long-term success
What This Means for Patients With Cancer History Clinicians at HealthRX apply a hard contraindication for BPC-157 use in any patient with a personal history of solid tumor malignancy or hematologic cancer, active or in remission, until prospective human carcinogenicity data exist
Inconsistent Dosing: Accurate, consistent dosing is the bedrock of good research
People with elevated blood levels of homocysteine
The breakthrough synthesis of BPC-157 arginate increased the 3% oral bioavailability of standard BPC-157 to greater than 90% in the arginate form
Q: How should providers counsel patients about endometriosis diagnosis uncertainty